The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
903
August 20, 1993
View Complete Issue         Table of Contents 2019 
Topical Terbinafine for Tinea Infections
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Topical Terbinafine for Tinea Infections
August 20, 1993 (Issue: 903)
Terbinafine 1% cream (Lamisil - Sandoz), an allylamine synthetic antifungal drug chemically related to naftifine (Naftin - Medical Letter, 30:98, 1988), is now available in the USA for topical treatment of tinea pedis, tinea cruris, and tinea...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Topical Terbinafine for Tinea Infections
Article code: 903b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.